NCT03402841 - Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients | Biotech Hunter

Enrollment

279

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

October 2, 2020

Study Completion Date

March 10, 2022

Conditions

Non-Germline BRCA Mutated Ovarian Cancer

Interventions

DRUG

Olaparib

300 mg twice daily - oral

Trial Locations (91)

424

Research Site, Oslo

1000

Research Site, Ljubljana

1011

Research Site, Lausanne

1090

Research Site, Vienna

1130

Research Site, Wein

1200

Research Site, Brussels

1205

Research Site, Geneva

1330

Research Site, Sofia

2610

Research Site, Wilrijk

3000

Research Site, Leuven

3010

Research Site, Bern

4000

Research Site, Plovdiv

4004

Research Site, Plovdiv

4031

Research Site, Basel

5000

Research Site, Namur

5053

Research Site, Bergen

6020

Research Site, Innsbruck

6280

Research Site, Loverval

6500

Research Site, Bellinzona

8035

Research Site, Barcelona

8036

Research Site, Graz

8091

Research Site, Zurich

8200

Research Site, Aarhus

8501

Research Site, Frauenfeld

9100

Research Site, Aalborg

10126

Research Site, Torino

10128

Research Site, Torino

14004

Research Site, Córdoba

17007

Research Site, Girona

18101

Research Site, Afula

20141

Research Site, Milan

23900

Research Site, Lecco

25123

Research Site, Brescia

28027

Research Site, Madrid

28046

Research Site, Madrid

29011

Research Site, Málaga

31008

Research Site, Pamplona

33520

Research Site, Tampere

35128

Research Site, Padua

41009

Research Site, Seville

46009

Research Site, Valencia

46026

Research Site, Valencia

52621

Research Site, Ramat Gan

60020

Research Site, Ancona

70210

Research Site, Kuopio

74101

Research Site, Nový Jičín

90029

Research Site, Oulu

91031

Research Site, Jerusalem

91096

Research Site, Haifa

400015

Research Site, Cluj-Napoca

400058

Research Site, Cluj-Napoca

4428164

Research Site, Kfar Saba

V8R 6V5

Research Site, Victoria

N6A 5W9

Research Site, London

K1H 8L6

Research Site, Ottawa

M5G2M9

Research Site, Toronto

H2X 0A9

Research Site, Montreal

J1H 5N4

Research Site, Sherbrooke

625 00

Research Site, Brno

775 20

Research Site, Olomouc

708 52

Research Site, Ostrava

128 08

Research Site, Prague

Unknown

Research Site, Beersheba

4818 CK

Research Site, Breda

5022 GC

Research Site, Tilburg

81-519

Research Site, Gdynia

31-501

Research Site, Krakow

20-090

Research Site, Lublin

10-513

Research Site, Olsztyn

60-569

Research Site, Poznan

02-781

Research Site, Warsaw

04-141

Research Site, Warsaw

3000-073

Research Site, Coimbra

1400-048

Research Site, Lisbon

031422

Research Site, Bucharest

08916

Research Site, Badalona

08036

Research Site, Barcelona

08041

Research Site, Barcelona

08907

Research Site, Hospitalet deLlobregat

581 85

Research Site, Linköping

221 85

Research Site, Lund

AB25 2ZN

Research Site, Aberdeen

CO4 5JL

Research Site, Colchester

EX2 5DW

Research Site, Exeter

LS9 7TF

Research Site, Leeds

LE1 5WW

Research Site, Leicester

SE1 9RT

Research Site, London

WC1N 3BG

Research Site, London

M20 4BX

Research Site, Manchester

NN1 5BD

Research Site, Northampton

YO12 6QL

Research Site, Scarborough